ARK Investment Management LLC lowered its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 52.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,468 shares of the company’s stock after selling 3,872 shares during the quarter. ARK Investment Management LLC’s holdings in ARK Genomic Revolution ETF were worth $89,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in ARKG. Chris Bulman Inc purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter valued at approximately $36,000. EverSource Wealth Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the 1st quarter valued at approximately $49,000. Larson Financial Group LLC boosted its holdings in ARK Genomic Revolution ETF by 4,576.1% in the 2nd quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock valued at $78,000 after purchasing an additional 3,249 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in ARK Genomic Revolution ETF by 9.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock valued at $109,000 after purchasing an additional 398 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the 2nd quarter valued at approximately $222,000.
ARK Genomic Revolution ETF Stock Performance
Shares of ARKG opened at $25.90 on Friday. The firm has a fifty day simple moving average of $24.88 and a 200 day simple moving average of $25.10.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Articles
- Five stocks we like better than ARK Genomic Revolution ETF
- How to Start Investing in Real Estate
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- How to Calculate Options Profits
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
